AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
LENSAR Inc
Video analysis: LNSR
All videosNo video analysis for this stock yet. Request one from our team.
News: LNSR
LENSAR Q2 Earnings Call Highlights
LENSAR NASDAQ: LNSR reported second-quarter 2026 revenue growth of 18% as the company continued to rebuild commercial momentum following the termination of its proposed merger with Alcon near the end of the first quarter.
LENSAR, Inc. (LNSR) Q2 2026 Earnings Call Transcript
LENSAR, Inc. (LNSR) Q2 2026 Earnings Call Transcript
LENSAR® Reports Second Quarter 2026 Results and Provides Business Update
10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026 Second Quarter Recurring Revenue was $13.7 million Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on key operational initiatives.
LENSAR Shareholders Re-Elect Directors, Back Executive Pay at 2026 Annual Meeting
LENSAR (NASDAQ: LNSR) shareholders elected three Class III directors, ratified the appointment of PricewaterhouseCoopers LLP as the company's independent auditor and approved advisory proposals on executive compensation during the company's 2026 annual meeting. The virtual meeting, held Aug. 4, was chaired by Board Chair Dr. William Link, who thanked shareholders for their participation and continued support.
